Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : L2P Research
Deal Size : Undisclosed
Deal Type : Partnership
Details : The partnership highlight the product line dealing with CD34+ cells and Humanized mouse models, both firms use the framework of collaborative business development to tackle competition and efficiency of research-grade stem cells.
Product Name : Undisclosed
Product Type : Cell and Gene therapy
Upfront Cash : Undisclosed
January 23, 2020
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : L2P Research
Deal Size : Undisclosed
Deal Type : Partnership
Reset All
